SCHEMBL20465503

SCHEMBL20465503

CC1(C)c2ccccc2-c2c(-c3nc(-n4c5ccccc5c5cc6c(cc54)c4ccccc4n6-c4ccccc4)c4ccccc4n3)cccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 5/20 0.36
CYP1A2 P05177 5/20 0.34
CYP3A4 P08684 5/20 0.34
CYP2D6 P10635 3/20 0.34
ALDH1A1 P00352 2/20 0.34
HSD17B10 Q99714 2/20 0.34
ABCG2 Q9UNQ0 5/20 0.33
TSHR P16473 3/20 0.33
CLK4 Q9HAZ1 2/20 0.33
MEN1 O00255 2/20 0.33
USP2 O75604 2/20 0.33
CYP2C19 P33261 2/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18456238 0.93 PTGER4 (0.36) KDM4EATML3MBTL1MAPTCYP1A2
SCHEMBL18456233 0.93 MAPT (0.34) KDM4EATML3MBTL1MAPTCYP1A2
SCHEMBL18455975 0.92 CYP1A2 (0.39) MAPTCYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL21212864 0.91 CYP1A2 (0.36) KDM4EMAPTCYP1A2CYP3A4CYP2D6
SCHEMBL18455574 0.90 CYP1A2 (0.36) MAPTCYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL18456255 0.88 MAPT (0.36) KDM4EATML3MBTL1MAPTCYP1A2
SCHEMBL18455575 0.87 TSHR (0.34) MAPTCYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL20465501 0.87 PTGER4 (0.33) MAPTCYP1A2CYP3A4CYP2D6HSD17B10
SCHEMBL18455502 0.85 CYP1A2 (0.34) MAPTCYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL18455573 0.85 CYP1A2 (0.32) MAPTCYP1A2CYP3A4CYP2D6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201296-B2 Compounds having fluorene structures MERCK PATENT GMBH (DE) 2021-12-14 US disclosed
US-20180226587-A1 COMPOUNDS HAVING FLUORENE STRUCTURES MERCK PATENT GMBH (DE) 2018-08-09 US disclosed
US-20180226587-A1 COMPOUNDS HAVING FLUORENE STRUCTURES MERCK PATENT GMBH (DE) 2018-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180226587-A1 COMPOUNDS HAVING FLUORENE STRUCTURES FSCN1, EFNA1, FLNA KDM4E 3228/4885ATM 4239/4885L3MBTL1 4011/4885
US-11201296-B2 Compounds having fluorene structures FSCN1, EFNA1, FLNA KDM4E 3228/4885ATM 4239/4885L3MBTL1 4011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.